Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Sep 16, 2021 8:57am

275 Views

Post# 33867617

Phase 2 "chronic cough" Bellus ( T.BLU ) vs. TLT

Just upgraded here in the US from $9 to $14/share USD - "WOW"

I suggest reading their latest 3 bullet point commentary in the recent release.

I also suggest looking at the FDA FAST TRACK TLT has secured

They are currently trading around $7.50 CAD on a per share basis...

Given they have ~ 1/3 our share count, this equates to a $2.50 TLT SP

I have a hard time with this comparison....WHO can help?

People benefitting from any kind of $ raise.."need not apply" ; - )

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments